Neftaly Goal: Decreasing Morbidity and Mortality Due to TB/HIV by Striving for Universal Access to TB/HIV Services
Tuberculosis (TB) and HIV co-infection pose a significant public health challenge, with each disease accelerating the progression and severity of the other. Neftaly is committed to reducing the burden of TB/HIV by ensuring that all affected populations have timely and equitable access to comprehensive, integrated TB/HIV prevention, diagnosis, and treatment services.
Our goal is to decrease morbidity and mortality from TB/HIV by striving for universal access to high-quality TB/HIV services across all levels of the health system.
Strategic Approaches
1. Integrated Service Delivery
- Promote the integration of TB and HIV services to provide one-stop, patient-centered care
- Strengthen collaboration between TB and HIV programmes to ensure coordinated screening, diagnosis, and treatment
- Expand access to antiretroviral therapy (ART) and TB preventive therapy for co-infected individuals
2. Early Diagnosis and Treatment
- Increase routine TB screening among people living with HIV and vice versa
- Scale up rapid diagnostic tools and ensure prompt initiation of appropriate treatment regimens
- Monitor treatment adherence and outcomes to improve success rates and reduce drug resistance
3. Community Engagement and Support
- Mobilize communities to raise awareness of TB/HIV co-infection risks and the importance of early care
- Strengthen community-based support systems to promote retention in care and adherence to treatment
- Address stigma and discrimination to improve health-seeking behavior and service uptake
4. Capacity Building and Health Systems Strengthening
- Train healthcare providers in TB/HIV integrated management and patient counseling
- Strengthen laboratory networks and supply chains to support reliable diagnosis and treatment
- Enhance data collection and use to monitor programme performance and identify gaps
Expected Impact
- Reduced TB incidence and mortality among people living with HIV
- Increased coverage of integrated TB/HIV services, ensuring patients receive timely and effective care
- Improved quality of life and survival rates for individuals affected by TB/HIV
- Progress toward national and global targets for TB and HIV control and elimination